retatrutide clinical trials netherlands Lilly's 'triple G' agonist triumphs in Phase III trial, but AEs unnerve analysts Retatrutide leads in obesity treatment

"From my experience it has been safe, effective and easy

10.1016/j.regpep.2009.11.005 20 GojkovicS.KrezicI.VrdoljakB.MalekinusicD.BarisicI.PetrovicA.et al (2020)

Long-Term Health Considerations For some individuals, especially those with obesity-related health conditions (like type 2 diabetes, high blood pressure, or cardiovascular issues), staying on GLP-1 medications for the long term might be necessary to manage overall health, not just weight loss

Cardiovascular illnesses, type 2 diabetes, obesity, and renal problems are all considerably more likely to develop in people with these symptoms [189,190]

A larger prospective study is necessary to clarify such a benefit

These are significant numbers for anyone struggling to stay within a healthy range